New Thai Health Minister Promises To Break Drug Patents
This article was originally published in PharmAsia News
Thailand's new health minister has made it clear he intends to use the country's compulsory licensing law to ensure Thais have access to key drugs at lower prices. Public Health Minister Chaovarat Chanweerakul's stance on the issue had been doubted by non-government organizations that feared he would side with drug makers and not use the CL policy. But at Chaovarat's arrival on the job, he promised he would break patents on life-saving drugs when necessary. (Click here for more
You may also be interested in...
Sanofi-Aventis sent a request to the previous Thai Minister of Commerce Mingkwan Sangsuwan to review the process of compulsory licensing on patented drugs, Graham Almond, Sanofi-Aventis Thailand general manager told PharmAsia News.
New chief medical officers take up positions at Abeona Therapeutics, Akcea Therapeutics and Oncologie, while there are new CFOs at Affimed, NGM Biopharmaceuticals, Phathom Pharmaceuticals, Oncologie and Syndax Pharmaceuticals.
Consumers in the UK can now self-select a version of Infirst's lipid-driven ibuprofen Flarin brand.